217 related articles for article (PubMed ID: 36907331)
1. Transcriptome analysis of CD4
Chen J; He Y; Zhong H; Hu F; Li Y; Zhang Y; Zhang X; Lin W; Li Q; Xu F; Chen S; Zhang H; Cai W; Li L
Virol Sin; 2023 Jun; 38(3):398-408. PubMed ID: 36907331
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 low-level viremia affects T cell activation rather than T cell development in school-age children, adolescents, and young adults during antiretroviral therapy.
Han J; Mu W; Zhao H; Hao Y; Song C; Zhou H; Sun X; Li G; Dai G; Zhang Y; Zhang F; Zeng H
Int J Infect Dis; 2020 Feb; 91():210-217. PubMed ID: 31821891
[TBL] [Abstract][Full Text] [Related]
3. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
[TBL] [Abstract][Full Text] [Related]
4. Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
Fleming J; Mathews WC; Rutstein RM; Aberg J; Somboonwit C; Cheever LW; Berry SA; Gebo KA; Moore RD;
AIDS; 2019 Nov; 33(13):2005-2012. PubMed ID: 31306175
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.
Zhang T; Ding H; An M; Wang X; Tian W; Zhao B; Han X
BMC Infect Dis; 2020 Feb; 20(1):147. PubMed ID: 32066392
[TBL] [Abstract][Full Text] [Related]
6. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
Bai R; Lv S; Hua W; Su B; Wang S; Shao Y; Li Z; Liu A; Sun L; Dai L
HIV Med; 2022 Mar; 23 Suppl 1():72-83. PubMed ID: 35293102
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
Bareng OT; Moyo S; Zahralban-Steele M; Maruapula D; Ditlhako T; Mokaleng B; Mokgethi P; Choga WT; Moraka NO; Pretorius-Holme M; Mine MO; Raizes E; Molebatsi K; Motswaledi MS; Gobe I; Mohammed T; Gaolathe T; Shapiro R; Mmalane M; Makhema JM; Lockman S; Essex M; Novitsky V; Gaseitsiwe S
J Antimicrob Chemother; 2022 Apr; 77(5):1385-1395. PubMed ID: 35229102
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study.
Brattgård H; Björkman P; Nowak P; Treutiger CJ; Gisslén M; Elvstam O
PLoS One; 2022; 17(5):e0268540. PubMed ID: 35580115
[TBL] [Abstract][Full Text] [Related]
10. Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.
Gaifer Z; Boulassel MR
J Int Assoc Provid AIDS Care; 2020; 19():2325958220979817. PubMed ID: 33372823
[TBL] [Abstract][Full Text] [Related]
11. Low-level Viremia in Treated HIV-1 Infected Patients: Advances and Challenges.
Bai R; Lv S; Wu H; Dai L
Curr HIV Res; 2022 Aug; 20(2):111-119. PubMed ID: 35170410
[TBL] [Abstract][Full Text] [Related]
12. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
Liu P; You Y; Liao L; Feng Y; Shao Y; Xing H; Lan G; Li J; Ruan Y; Li D
BMC Infect Dis; 2022 May; 22(1):426. PubMed ID: 35509014
[TBL] [Abstract][Full Text] [Related]
13. Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.
Delaugerre C; Gallien S; Flandre P; Mathez D; Amarsy R; Ferret S; Timsit J; Molina JM; de Truchis P
PLoS One; 2012; 7(5):e36673. PubMed ID: 22590588
[TBL] [Abstract][Full Text] [Related]
14. Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.
Lao X; Zhang H; Deng M; Li Q; Xiao Q; He L; Ma L; Song A; Liang X; Yu F; Zhao H; Zhang F
BMC Infect Dis; 2024 Jan; 24(1):8. PubMed ID: 38166689
[TBL] [Abstract][Full Text] [Related]
15. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort.
Elvstam O; Malmborn K; Elén S; Marrone G; García F; Zazzi M; Sönnerborg A; Böhm M; Seguin-Devaux C; Björkman P
Clin Infect Dis; 2023 Jan; 76(1):25-31. PubMed ID: 36100984
[TBL] [Abstract][Full Text] [Related]
16. Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution.
Kauffman RC; Villalobos A; Bowen JH; Adamson L; Schinazi RF
PLoS One; 2014; 9(2):e88258. PubMed ID: 24505452
[TBL] [Abstract][Full Text] [Related]
17. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
[TBL] [Abstract][Full Text] [Related]
18. Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.
Ryscavage P; Kelly S; Li JZ; Harrigan PR; Taiwo B
Antimicrob Agents Chemother; 2014 Jul; 58(7):3585-98. PubMed ID: 24733471
[TBL] [Abstract][Full Text] [Related]
19. Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.
Elvstam O; Medstrand P; Yilmaz A; Isberg PE; Gisslén M; Björkman P
PLoS One; 2017; 12(7):e0180761. PubMed ID: 28683128
[TBL] [Abstract][Full Text] [Related]
20. Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Álvarez H; Mocroft A; Ryom L; Neesgaard B; Edwards S; Svedhem V; Günthard HF; Zangerle R; Smith C; Castagna A; d'Arminio Monforte A; Wit F; Stecher M; Lehman C; Mussini C; Fontas E; González E; Wasmuth JC; Sönnerborg A; De Wit S; Chkhartishvili N; Stephan C; Petoumenos K; Jaschinski N; Vannappagari V; Gallant J; Young L; Volny Anne A; Greenberg L; Martín-Iguacel R; Poveda E; Llibre JM;
Clin Infect Dis; 2023 Aug; 77(4):593-605. PubMed ID: 37052343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
